Results for tag: "Altretamine"

Altretamine is a chemotherapy drug used to treat ovarian cancer. It is classified as an alkylating agent, meaning it works by damaging the DNA of cancer cells, preventing them from growing and dividing. Altretamine is usually used in combination with other chemotherapy drugs, such as cisplatin or carboplatin. It is typically administered intravenously, and is usually given in cycles of three to six weeks. Common side effects of altretamine include nausea, vomiting, hair loss, fatigue, and anemia. Altretamine is a relatively new drug, and is not widely used in the treatment of ovarian cancer. However, it has been shown to be effective in some cases, and is often used in combination with other chemotherapy drugs. It is also used in combination with other treatments, such as radiation therapy and surgery. The altretamine market is a small but growing one, with several companies developing and marketing the drug. These include Teva Pharmaceuticals, Mylan Pharmaceuticals, and Sun Pharmaceuticals. Other companies, such as Pfizer and Merck, are also researching and developing new formulations of altretamine. Show Less Read more